SCHEDULE FILED TO REPORT ACQUISITION

Company

Ovid Therapeutics Inc.

Filed

February 14, 2019

Accession Number

0001387131-19-001273

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →